Pharmaffiliates is excited to exhibit at Arab Lab, where it will spotlight its end-to-end CRDMO services provider capabilities in India, catering to both small and large molecules. As a trusted concept-to-commercial CDMO partner, the company will highlight its holistic development solutions—including spray dried dispersions and scalable manufacturing expertise.

The exhibit will also emphasize Pharmaffiliates’ integrated biologics process development services, including biologic early development services in India. Visitors will gain insight into the company’s CHO DG44 platform for biologics manufacturing, enabling cutting-edge biologics production workflows. don't forget to visit :https://www.pharmaffiliates.com/en/arab-lab

For clients focused on precision and regulatory confidence, Pharmaffiliates will promote its monoclonal antibody analytics suite, along with high-throughput screening CRO India services tailored for early-stage biologic development.

This participation demonstrates Pharmaffiliates’ commitment to offering a seamless continuum—from early concept and small/large molecule optimization to manufacturing readiness and analytical rigor—positioning the company as a comprehensive CRDMO and biologics partner.